SCHEMBL614042

SCHEMBL614042

Cc1c2ccnc(Cl)c2cc2c1[nH]c1ccc(OCc3ccccc3)cc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 6/20 0.55
TRPM8 Q7Z2W7 1/20 0.47
NQO2 P16083 1/20 0.47
GABRA1 P14867 1/20 0.47
GABRG2 P18507 1/20 0.47
GABRB3 P28472 1/20 0.47
GABRA5 P31644 1/20 0.47
GABRA3 P34903 1/20 0.47
GABRA2 P47869 1/20 0.47
CHEK1 O14757 1/20 0.46
KIT P10721 1/20 0.45
KDM4E B2RXH2 2/20 0.45
MAPT P10636 2/20 0.45
MAOB P27338 1/20 0.45
LMNA P02545 1/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.45
HSD17B10 Q99714 1/20 0.45
DYRK1A Q13627 1/20 0.44
BCHE P06276 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL613815 0.86 MAOA (0.54) MAOATRPM8NQO2GABRA1GABRG2
SCHEMBL614041 0.83 KIT (0.58) MAOANQO2KITKDM4EMAPT
SCHEMBL11096433 0.82 MAOA (0.55) MAOANQO2KITKDM4EMAPT
SCHEMBL615545 0.79 MAOA (0.53) MAOATRPM8GABRA1GABRG2GABRB3
SCHEMBL614704 0.78 KIT (0.53) NQO2GABRA1GABRG2GABRB3GABRA5
SCHEMBL11160990 0.77 KIT (0.69) MAOATRPM8GABRA1GABRG2GABRB3
SCHEMBL31362095 0.77 KIT (0.69) MAOATRPM8GABRA1GABRG2GABRB3
SCHEMBL100339 0.74 TRPM8 (0.60) MAOATRPM8GABRA1GABRG2GABRB3
SCHEMBL7003847 0.72 PLAU (0.61) MAOAMAPTMAOBLMNADYRK1A
SCHEMBL2311050 0.72 KIT (0.49) NQO2KITKDM4EMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8604048-B2 Pyridocarbazole type compounds and applications thereof CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-12-10 US disclosed
US-20120041017-A1 PYRIDOCARBAZOLE TYPE COMPOUNDS AND APPLICATIONS THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041017-A1 PYRIDOCARBAZOLE TYPE COMPOUNDS AND APPLICATIONS THEREOF NLN, OPA1, PYCR1 MAOA 331/4885TRPM8 4248/4885NQO2 156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.